The Challenge
Lubrizol retained PharmaBioSource as its exclusive consultant to divest Particle Sciences, its Bethlehem, Pennsylvania-based specialty drug product formulation development contract development and manufacturing subsidiary. The 50,000-square-foot laboratory and clinical oral solids and semi-solids manufacturing facility with nanoparticle and nanomilling capabilities also housed a brand-new sterile injectable filling suite.
The Solution
PharmaBioSource marketed the business and facility to strategic acquirers.
Services provided by the PharmaBioSource team:
- Buyer target identification and engagement
- Creation of the Confidential Information Memorandum (CIM)
- Marketing
- Data room development
- Due diligence support
- Negotiations and closing support
The Results
PharmaBioSource identified Agno Pharma as the acquirer. Agno Pharma acquired Particle Sciences in a fast-paced transaction process of three months.
What We Did
Sell-Side Advisory
Divestiture